Literature DB >> 29734042

In vitro studies identify a low replication phenotype for hepatitis B virus genotype H generally associated with occult HBV and less severe liver disease.

Vitina Sozzi1, Fang Shen2, Jieliang Chen2, Danni Colledge1, Kathy Jackson1, Stephen Locarnini1, Zhenghong Yuan2, Peter A Revill3.   

Abstract

Hepatitis B virus (HBV) exists as 9 major genotypes and multiple subtypes, many of which exhibit differences in pathogenicity and treatment response. Genotype H identified in Central America is associated with low incidence of liver disease and HCC, but higher incidence of occult HBV (low level HBV DNA positivity, HBsAg negative). The replication phenotype of genotype H associated with less severe forms of liver disease is unknown. We hypothesized that the reduced pathogenesis associated with this genotype may be due to by lower rates of viral replication and/or secretion compared to other characterised strains. We used transient transfection and infection cell culture models to characterise the replication phenotype, compared to our D3 reference strain. Genotype H exhibited reduced viral replication and altered envelope protein expression compared to genotype D, with functional studies showing that low replication was in part likely due to sequence differences in the major transcriptional regulatory region.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Genotype; HBV; Infection; Replication; Secretion; Transfection

Mesh:

Substances:

Year:  2018        PMID: 29734042     DOI: 10.1016/j.virol.2018.04.015

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

Review 1.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

2.  A PCR assay to quantify patterns of HBV transcription.

Authors:  Valentina D'Arienzo; Andrea Magri; James M Harris; Peter A C Wing; Chunkyu Ko; Claudia Orbegozo Rubio; Peter A Revill; Ulrike Protzer; Peter Balfe; Jane A McKeating
Journal:  J Gen Virol       Date:  2019-12-17       Impact factor: 3.891

3.  Efficacy and safety of spleen aminopeptide oral lyophilized powder in ameliorating liver injury in infants and children with human cytomegalovirus infection: a single-center study in China.

Authors:  Yanling Wu; Xueting Dong; Runqiu Wu; Xinguo Zheng; Yu Jin; Hui Yang
Journal:  Transl Pediatr       Date:  2021-01

4.  Distribution of hepatitis B virus genotypes and subgenotypes: A meta-analysis.

Authors:  Zhongping Liu; Yafei Zhang; Mengyuan Xu; Xu Li; Zhenhua Zhang
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

5.  Moving Fast Toward Hepatitis B Virus Elimination.

Authors:  Leda Bassit; Suzane Kioko Ono; Raymond F Schinazi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Infection courses, virological features and IFN-α responses of HBV genotypes in cell culture and animal models.

Authors:  Min Zhang; Zhensheng Zhang; Michio Imamura; Mitsutaka Osawa; Yuji Teraoka; Jason Piotrowski; Yuji Ishida; Vitina Sozzi; Peter A Revill; Takeshi Saito; Kazuaki Chayama; T Jake Liang
Journal:  J Hepatol       Date:  2021-08-04       Impact factor: 30.083

7.  Association of TLR3 (rs3775291) and IL-10 (rs1800871) gene polymorphisms with susceptibility to Hepatitis B infection: A meta-analysis.

Authors:  Susu Ye; Xinlei Zhang; Yu Bao Zhang; Xintao Tian; Ailing Liu; Changxing Cui; Lei Shi; Di Xia
Journal:  Epidemiol Infect       Date:  2020-09-11       Impact factor: 2.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.